Critical Reviews in Oncology/Hematology, 1040-8428
Journal
1 - 50 out of 57Page size: 50
- 2020
- 2019
- Mattes, K., Vellenga, E., & Schepers, H. (2019). Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy. Critical Reviews in Oncology/Hematology, 144, [102814]. https://doi.org/10.1016/j.critrevonc.2019.102814
- Kleine, A-K., Hallensleben, N., Mehnert, A., Hoenig, K., & Ernst, J. (2019). Psychological interventions targeting partners of cancer patients: A systematic review. Critical Reviews in Oncology/Hematology, 140, 52-66. https://doi.org/10.1016/j.critrevonc.2019.05.008
- 2018
- Montes de Jesus, F. M., Kwee, T. C., Nijland, M., Kahle, X. U., Huls, G., Dierckx, R. A. J. O., van Meerten, T., Gheysens, O., Dierickx, D., Vergote, V., Noordzij, W., & Glaudemans, A. W. J. M. (2018). Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 132, 27-38. https://doi.org/10.1016/j.critrevonc.2018.09.007
- Amelung, F. J., Burghgraef, T. A., Tanis, P. J., van Hooft, J. E., ter Borg, F., Siersema, P. D., Bemelman, W. A., & Consten, E. C. J. (2018). Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 131, 66-75. https://doi.org/10.1016/j.critrevonc.2018.08.003
- Clemens, E., van der Kooi, A. L. F., Broer, L., Van Dulmen-den Broeder, E., Visscher, H., Kremer, L., Tissing, W., Loonen, J., Ronckers, C. M., Pluijm, S. M. F., Neggers, S. J. C. M. M., Zolk, O., Langer, T., Zehnhoff-Dinnese, A. A., Wilson, C. L., Hudson, M. M., Carleton, B., Laven, J. S. E., Uitterlinden, A. G., & van den Heuvel-Eibrink, M. M. (2018). The influence of genetic variation on late toxicities in childhood cancer survivors: A review. Critical Reviews in Oncology/Hematology, 126, 154-167. https://doi.org/10.1016/j.critrevonc.2018.04.001
- 2017
- 2016
- Helfferich, J., Nijmeijer, R., Brouwer, O. F., Boon, M., Fock, A., Hoving, E. W., Meijer, L., den Dunnen, W. F. A., & de Bont, E. S. J. M. (2016). Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Critical Reviews in Oncology/Hematology, 104, 30-41. https://doi.org/10.1016/j.critrevonc.2016.05.008
- De Sanctis, V., Bossi, P., Sanguineti, G., Trippa, F., Ferrari, D., Bacigalupo, A., Ripamonti, C. I., Buglione, M., Pergolizzi, S., Langendijk, J. A., Murphy, B., Raber-Durlacher, J., Russi, E. G., & Lalla, R. V. (2016). Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Critical Reviews in Oncology/Hematology, 100, 147-166. https://doi.org/10.1016/j.critrevonc.2016.01.010
- van der Wekken, A., Saber, A., Hiltermann, T., Kok, K., van den Berg, A., & Groen, H. J. M. (2016). Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature. Critical Reviews in Oncology/Hematology, 100, 107-116. https://doi.org/10.1016/j.critrevonc.2016.01.024
- van Marion, D. M. S., Domanska, U. M., Timmer-Bosscha, H., & Walenkamp, A. M. E. (2016). Studying cancer metastasis: Existing models, challenges and future perspectives. Critical Reviews in Oncology/Hematology, 97, 107-117. https://doi.org/10.1016/j.critrevonc.2015.08.009
- 2015
- Schindler, A., Denaro, N., Russi, E. G., Pizzorni, N., Bossi, P., Merlotti, A., Bissetti, M. S., Numico, G., Gava, A., Orlandi, E., Caspiani, O., Buglione, M., Alterio, D., Bacigalupo, A., De Sanctis, V., Pavanato, G., Ripamonti, C., Merlano, M. C., Licitra, L., ... Murphy, B. (2015). Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. Critical Reviews in Oncology/Hematology, 96(2), 372-384. https://doi.org/10.1016/j.critrevonc.2015.06.005
- Russi, E. G., Moretto, F., Rampino, M., Benasso, M., Bacigalupo, A., De Sanctis, V., Numico, G., Bossi, P., Buglione, M., Lombardo, A., Airoldi, M., Merlano, M. C., Licitra, L., Denaro, N., Pergolizzi, S., Pinto, C., Bensadoun, R-J., Girolomoni, G., & Langendijk, J. A. (2015). Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. Critical Reviews in Oncology/Hematology, 96(1), 167-182. https://doi.org/10.1016/j.critrevonc.2015.06.001
- Bouma, G., Admiraal, L. M., de Vries, E. G. E., Schröder, C. P., Walenkamp, A. M. E., & Reyners, A. K. L. (2015). Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: A literature analysis. Critical Reviews in Oncology/Hematology, 95(1), 26-37. https://doi.org/10.1016/j.critrevonc.2015.01.011
- 2014
- Pavlov, K., Meijer, C., van den Berg, A., Peters, F. T. M., Kruyt, F. A. E., & Kleibeuker, J. H. (2014). Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities. Critical Reviews in Oncology/Hematology, 92(1), 25-37. https://doi.org/10.1016/j.critrevonc.2014.05.002
- Sie, M., den Dunnen, W. F. A., Hoving, E. W., & de Bont, E. S. J. M. (2014). Anti-angiogenic therapy in pediatric brain tumors: An effective strategy? Critical Reviews in Oncology/Hematology, 89(3), 418-432. https://doi.org/10.1016/j.critrevonc.2013.09.005
- 2013
- de Wilt, L. H. A. M., Kroon, J., Jansen, G., de Jong, S., Peters, G. J., & Kruyt, F. A. E. (2013). Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells? Critical Reviews in Oncology/Hematology, 85(3), 363-372. https://doi.org/10.1016/j.critrevonc.2012.08.001
- 2012
- van der Bilt, A. R. M., de Vries, E. G. E., de Jong, S., Timmer-Bosscha, H., van der Zee, A. G. J., & Reyners, A. K. L. (2012). Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer. Critical Reviews in Oncology/Hematology, 84(2), 224-242. https://doi.org/10.1016/j.critrevonc.2012.03.006
- Van Gaal, J. C., De Bont, E. S. J. M., Kaal, S. E. J., Versleijen-Jonkers, Y., & van der Graaf, W. T. A. (2012). Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead. Critical Reviews in Oncology/Hematology, 82(3), 259-279. https://doi.org/10.1016/j.critrevonc.2011.06.005
- Sikkema, A. H., den Dunnen, W. F. A., Diks, S. H., Peppelenbosch, M. P., & de Bont, E. S. J. M. (2012). Optimizing targeted cancer therapy: Towards clinical application of systems biology approaches. Critical Reviews in Oncology/Hematology, 82(2), 171-186. https://doi.org/10.1016/j.critrevonc.2011.05.002
- Fiebrich, H-B., van Asselt, S. J., Brouwers, A. H., van Dullemen, H. M., Pijl, M. E. J., Elsinga, P. H., Links, T. P., & de Vries, E. G. E. (2012). Tailored imaging of islet cell tumors of the pancreas amidst increasing options. Critical Reviews in Oncology/Hematology, 82(2), 213-226. https://doi.org/10.1016/j.critrevonc.2011.05.006
- 2011
- Heijink, D. M., de Vries, E. G. E., Koornstra, J. J., Hospers, G. A. P., Hofstra, R. M. W., van Vugt, M. A. T. M., de Jong, S., & Kleibeuker, J. H. (2011). Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome. Critical Reviews in Oncology/Hematology, 80(2), 264-277. https://doi.org/10.1016/j.critrevonc.2010.11.009
- Van Leeuwen, B. L., Rosenkranz, K. M., Feng, L. L., Bedrosian, I., Hartmann, K., Hunt, K. K., Kuerer, H. M., Ross, M., Singletary, S. E., & Babiera, G. V. (2011). The effect of under-treatment of breast cancer in women 80 years of age and older. Critical Reviews in Oncology/Hematology, 79(3), 315-320. https://doi.org/10.1016/j.critrevonc.2010.05.010
- Domanska, U. M., Kruizinga, R. C., den Dunnen, W. F. A., Timmer-Bosscha, H., de Vries, E. G. E., & Walenkamp, A. M. E. (2011). The chemokine network, a newly discovered target in high grade gliomas. Critical Reviews in Oncology/Hematology, 79(2), 154-163. https://doi.org/10.1016/j.critrevonc.2010.07.006
- 2009
- Poele, E. M. T., Tissing, W. J. E., Kamps, W. A., & de Bont, E. S. J. M. (2009). Risk assessment in fever and neutropenia in children with cancer: What did we learn? Critical Reviews in Oncology/Hematology, 72(1), 45-55. https://doi.org/10.1016/j.critrevonc.2008.12.009
- Koopmans, K. P., Neels, O. N., Kema, I. P., Elsinga, P. H., Links, T. P., de Vries, E. G. E., & Jager, P. L. (2009). Molecular imaging in neuroendocrine tumors: Molecular uptake mechanisms and clinical results. Critical Reviews in Oncology/Hematology, 71(3), 199-213. https://doi.org/10.1016/j.critrevonc.2009.02.009
- Roorda, B. D., ter Elst, A., Kamps, W. A., & de Bont, E. S. J. M. (2009). Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Critical Reviews in Oncology/Hematology, 69(3), 187-198. https://doi.org/10.1016/j.critrevonc.2008.06.004
- 2007
- Corgna, E., Betti, M., Gatta, G., Roila, F., & De Mulder, P. H. M. (2007). Renal cancer. Critical Reviews in Oncology/Hematology, 64(3), 247-261. https://doi.org/10.1016/j.critrevonc.2007.04.007
- de Jonge-Peeters, S. D. P. W. M., Kuipers, F., de Vries, E. G. E., & Vellenga, E. (2007). ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Critical Reviews in Oncology/Hematology, 62(3), 214-226. https://doi.org/10.1016/j.critrevonc.2007.02.003
- 2006
- de Hullu, J. A., & van der Zee, A. G. J. (2006). Surgery and radiotherapy in vulvar cancer. Critical Reviews in Oncology/Hematology, 60(1), 38-58. https://doi.org/10.1016/j.critrevonc.2006.02.008
- Mom, CH., Buijs, C., Willemse, PHB., Mourits, MJE., & de Vries, EGE. (2006). Hot flushes in breast cancer patients. Critical Reviews in Oncology/Hematology, 57(1), 63-77. https://doi.org/10.1016/j.critrevonc.2005.04.009
- 2005
- Farshadpour, F., Schaapveld, M., Suurmeijer, AJH., Wymenga, ANM., Otter, R., & Hoekstra, HJ. (2005). Soft tissue sarcoma: why not treated? Critical Reviews in Oncology/Hematology, 54(1), 77-83. https://doi.org/10.1016/j.critrevonc.2004.10.006
- Perik, PJ., de Vries, EGE., Gietema, JA., van der Graaf, WTA., Sleijfer, DT., Suurmeijer, AJH., & van Veldhuisen, DJ. (2005). The dilemma of the strive for apoptosis in oncology: mind the heart. Critical Reviews in Oncology/Hematology, 53(2), 101-113. https://doi.org/10.1016/j.critrevonc.2004.10.001
- 2004
- Groninger, E., Proost, J. H., & de Graaf, S. S. N. (2004). Pharmacokinetic studies in children with cancer. Critical Reviews in Oncology/Hematology, 52(3), 173-197. https://doi.org/10.1016/j.critrevonc.2004.08.007
- Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004). The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Critical Reviews in Oncology/Hematology, 50(2), 87 - 100. https://doi.org/10.1016/j.critrevonc.2003.09.001
- 2003
- Koornstra, JJ., de Jong, S., Hollema, H., de Vries, EGE., & Kleibeuker, JH. (2003). Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Critical Reviews in Oncology/Hematology, 45(1), 37-53. [PII S1040-8428(01)00228-1].
- 2002
- Klimp, AH., de Vries, EGE., Scherphof, GL., & Daemen, T. (2002). A potential role of macrophage activation in the treatment of cancer. Critical Reviews in Oncology/Hematology, 44(2), 143-161. [PII S1040-8428(01)00203-7].
- Nijhuis, CSMO., Daenen, SMGJ., Vellenga, E., van der Graaf, WTA., Gietema, JA., Groen, HJM., Kamps, WA., & de Bont, ESJM. (2002). Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies. Critical Reviews in Oncology/Hematology, 44(2), 163-174. [PII S1040-8428(01)00220-7].
- 2001
- McLaughlin, PMJ., Kroesen, BJ., Harmsen, MC., & de Leij, LFMH. (2001). Cancer immunotherapy: insights from transgenic animal models. Critical Reviews in Oncology/Hematology, 40(1), 53-76.
ID: 1254770